Related Experiment Videos
MELD 3.0 is a more accurate predictor of mortality in decompensated cirrhosis than MELD and MELD-Na
Amal Khsiba1, Sahar Chtioui1, Moufida Mahmoudi1
1Gastroenterology department, Hospital of Nabeul, Faculty of medecine of Tunis, University of Tunis el Manar, Tunis, Tunisia.
Backgroud And Aim:
Prognostic scores guide organ allocation in cirrhosis.We assessed the performance of MELD, MELD-Na, and MELD 3.0 for predicting mortality in decompensated Tunisian cirrhotic patients Methods: We conducted a retrospective study including decompensated cirrhosis patients in a Tunisian gastroenterology department.
Results:
152 patients were enrolled (mean age 61 years; viral etiology 65.1%). Mean MELD-Na and MELD 3.0 were 17.7 and 19.4. Mean follow-up: 17.1 months. Decompensation rate: 33.6%; 3-month mortality: 18.4%. For 3-month mortality, AUROCs were 0.786 (MELD), 0.841 (MELD-Na), and 0.850 (MELD 3.0). MELD 3.0 cut-off of 24 yielded sensitivity 68%, specificity 88% (p=0.04 for association with mortality).
Conclusion:
MELD 3.0 outperformed MELD and MELD-Na in predicting mortality. A MELD 3.0 score ≥24 identifies patients who should be prioritized on the transplant waiting list.
Insights
The MELD 3.0 score accurately predicts mortality in Tunisian patients with decompensated cirrhosis, outperforming MELD and MELD-Na. A score of 24 or higher indicates priority for liver transplantation.
Area of Science:
- Hepatology
- Transplant Medicine
- Medical Statistics
Background:
- Prognostic scores are crucial for organ allocation in cirrhosis patients.
- Evaluating the efficacy of existing scores in specific patient populations is essential.
Purpose of the Study:
- To assess the performance of MELD, MELD-Na, and MELD 3.0 in predicting mortality.
- To evaluate these scores in Tunisian patients with decompensated cirrhosis.
Main Methods:
- Retrospective study of 152 decompensated cirrhosis patients in Tunisia.
- Analysis of 3-month mortality using MELD, MELD-Na, and MELD 3.0 scores.
- Calculation of Area Under the Receiver Operating Characteristic Curve (AUROC) for each score.
Main Results:
- MELD 3.0 demonstrated the highest AUROC (0.850) for predicting 3-month mortality.
- MELD-Na (0.841) also showed improved performance over MELD (0.786).
- A MELD 3.0 cut-off of 24 achieved 68% sensitivity and 88% specificity for mortality.
Conclusions:
- MELD 3.0 is a superior predictor of mortality in this cohort compared to MELD and MELD-Na.
- A MELD 3.0 score ≥24 can identify patients needing prioritized liver transplant listing.
Related Concept Videos
Cirrhosis II: Pathophysiology
Cirrhosis I: Introduction
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Acute Coronary Syndrome III: Diagnostic Studies